GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (XSGO:AMGN) » Definitions » Dividends per Share

Amgen (XSGO:AMGN) Dividends per Share : $8.52 (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Amgen Dividends per Share?

Amgen's dividends per share for the three months ended in Dec. 2023 was $2.13. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was $8.52. Its Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.45. As of today, Amgen's Dividend Yield % is 0.00%.

During the past 12 months, Amgen's average Dividends Per Share Growth Rate was 9.80% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 10.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Amgen was 63.30% per year. The lowest was 10.00% per year. And the median was 15.95% per year.

For more information regarding to dividend, please check our Dividend Page.


Amgen Dividends per Share Historical Data

The historical data trend for Amgen's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Dividends per Share Chart

Amgen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.80 6.40 7.04 7.76 8.52

Amgen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 2.13 2.13 2.13 2.13

Competitive Comparison of Amgen's Dividends per Share

For the Drug Manufacturers - General subindustry, Amgen's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Amgen's Dividend Yield % falls into.



Amgen Dividends per Share Calculation

Dividends paid to per common share.


Amgen  (XSGO:AMGN) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Amgen's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2023 )/ EPS without NRI (Q: Dec. 2023 )
=2.13/ 4.71
=0.45

During the past 13 years, the highest Dividend Payout Ratio of Amgen was 1.71. The lowest was 0.35. And the median was 0.45.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Amgen Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 2.2500002024-02-152024-02-162024-03-07Cash DividendquarterlyUSD:USD 1.000000
USD 2.1300002023-11-162023-11-172023-12-08Cash DividendquarterlyUSD:USD 1.000000
USD 2.1300002023-08-172023-08-182023-09-08Cash DividendquarterlyUSD:USD 1.000000
USD 2.1300002023-05-172023-05-182023-06-08Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.


Amgen's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=8.64/255.16
=3.39 %

Current Share Price is $255.16.
Amgen's Dividends per Share for the trailing twelve months (TTM) ended in Today is $8.64.

During the past 13 years, the highest Dividend Yield of Amgen was 3.72%. The lowest was 0.00%. And the median was 2.57%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amgen Dividends per Share Related Terms

Thank you for viewing the detailed overview of Amgen's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Amgen (XSGO:AMGN) Business Description

Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen (XSGO:AMGN) Headlines

From GuruFocus

Amgen Inc at Wells Fargo Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Amgen Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024

Amgen Inc To Acquire Horizon Therapeutics Transcript

By GuruFocus Research 01-22-2024

Q1 2023 Amgen Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Amgen Inc Investor Call from AHA 2022 Transcript

By GuruFocus Research 01-22-2024

Amgen Inc ESMO Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 Amgen Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Amgen Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-22-2024